Akshay Sharma

In this insightful discussion, Dr. Akshay Sharma, a hematologist at St. Jude Children’s Research Hospital, explores the cutting-edge field of gene therapy for sickle cell disease. He details key considerations for selecting patients, emphasizing organ function and pre-existing health conditions. The conversation highlights the complex benefits and challenges of gene therapy, including the risk of leukemia linked to lentiviral treatments. Additionally, Dr. Sharma addresses the evolving role of palliative care in enhancing patient comfort during such innovative therapies.